Article Figures & Data
Figures
- Fig 1.
Discharge modified mRS scores in patients ≥80 years of age versus younger patients.
Tables
- Table 1:
Cohort age distribution by deciles in patients undergoing Merci thrombectomy for acute ischemic stroke
Decile Age (yr) Decile Age (yr) 1st 14–39 6th 71–74 2nd 39–47 7th 74–78 3rd 48–56 8th 78–83 4th 56–64 9th 84–86 5th 65–70 10th 86–95 - Table 2:
Baseline characteristics of patients undergoing Merci thrombectomy for acute ischemic strokea
Age <80 yr (n = 75) Age ≥80 yr (n = 31) P Age (yr) 57.5 ± 16.0 85.9 ± 3.8 Male sex 38 (51) 10 (32) .1 Dominant hemisphere or vertebrobasilar 39 (52) 20 (65) .2 Anterior circulation 70 (93) 30 (97) .7 Premorbid history of Cardiac disease 38 (51) 21 (68) .1 Hypertension 41 (55) 21 (68) .2 Hyperlipidemia 22 (29) 10 (32) .8 Diabetes 16 (21) 2 (6) .9 Prior stroke or TIA 3 (4) 1 (3) 1 Peripheral vascular disease 4 (5) 2 (6) 1 Cardioembolic source 41 (55) 25 (81) .02 AOL 2–3 58 (77) 25 (81) .8 Time to intervention (hr) 6:25 ± 2:49 6:21 ± 2:17 .9 Persistent mismatch following Mercib 35/67 (52) 16/29 (55) .8 Intravenous or IA thrombolytic 27 (36) 11 (35) 1 Adjunctive therapy 6 (8) 2 (6) 1 Admission glucose (mg/dL) 142 ± 65 141 ± 42 .9 a Baseline characteristic, No. (%) unless otherwise specified.
b Eight patients younger than 80 year of age and 2 older did not have interpretable perfusion images.
- Table 3:
Clinical outcomes, secondary end points, and HT in patients undergoing Merci thrombectomy for acute ischemic strokea
Age <80 yr (n = 75) Age ≥80 yr (n = 31) Pb Age 65–79 yr (n = 33) Pb Admission NIHSS 18 (13–22) 20 (18–23) .1 17 (15–23) .3 Hospital length of stay (days)c 10.4 ± 8.0 8.3 ± 5.0 .3 6.2 ± 3.0 .1 Stroke-related death 11 (15) 15 (48) 5.5 (2.1–14.1) 8 (24) 2.9 (1.0–8.5) Discharge NIHSS 6.5 (2–42) 42 (6–42) .006 11 (3–42) .09 Discharge NIHSS in survivorsd 5 (2–12) 5.5 (2–11) 1 4 (0–11) .8 NIHSS change 4.2 ± 14.4 −4.9 ± 16.9 .01 1.7 ± 15.8 .1 NIHSS change in survivorsd 9.4 ± 8.6 10.4 ± 5.5 .7 10.1 ± 7.5 .9 Discharge mRS 4 (1–5) 5 (3.5–6) .006 3 (0.5–4) .1 Discharge mRS in survivorsd 3 (1–4) 3.5 (2–4) .9 2 (0–4) .7 mRS ≤2 in survivorsd 25/62 (40) 6/16 (38) .9 (.3–2.8) 11/23 (48) 0.7 (.2–2.4) HTe Any HT within 72 hr 30/72 (42) 17/28 (61) 2.2 (.9–5.3) 13/30 (43) 2.0 (.7–5.8) Symptomatic HT within 72 hr 7/72 (10) 3/28 (11) .9 (.2–3.7) 2/30 (7) 1.7 (.3–10.9) Parenchymal HT within 72 hr 9/72 (13) 4/28 (14) 1.2 (.3–4.1) 3/30 (10) 1.5 (.3–7.4) a Clinical measure, No. (%) unless otherwise specified; all NIHSS and mRS values except NIHSS change are shown as median (interquartile range).
b ORs (95% CI) are shown for selected comparisons.
c One patient with a prolonged hospitalization due to surgery unrelated to the stroke was excluded from LOS analysis.
d Patients who died were not analyzed in these comparisons.
e Three patients in each group did not undergo imaging by 72 hours to determine HT.
In this issue
Jump to section
Related Articles
Cited By...
- Predictors of independent outcome of thrombectomy in stroke patients with large baseline infarcts in clinical practice: a multicenter analysis
- Endovascular treatment in older adults with acute ischemic stroke in the MR CLEAN Registry
- An international multicenter retrospective study to survey the landscape of thrombectomy in the treatment of anterior circulation acute ischemic stroke: outcomes with respect to age
- Using machine learning to optimize selection of elderly patients for endovascular thrombectomy
- Outcomes of endovascular thrombectomy in the elderly: a 'real-world multicenter study
- Thrombectomy for acute ischemic stroke in the elderly: a 'real world experience
- Efficacy of intra-arterial therapy in the elderly requires further study
- Efficacy of endovascular stroke management in elderly patients
- Patient Selection for Stroke Endovascular Therapy-- DWI-ASPECTS Thresholds Should Vary among Age Groups: Insights from the RECOST Study
- Influence of Age on Clinical and Revascularization Outcomes in the North American Solitaire Stent-Retriever Acute Stroke Registry
- Multimodal endovascular management of acute ischemic stroke in patients over 75 years old is safe and effective
- Elderly Patients Are at Higher Risk for Poor Outcomes After Intra-Arterial Therapy
- Patient Outcomes With Endovascular Embolectomy Therapy for Acute Ischemic Stroke: A Study of the National Inpatient Sample: 2006 to 2008